Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

PRINCETON, N.J., Nov. 17, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...

Related Keywords

,Development Authority ,Linkedin ,Soligenix Inc ,Biomedical Advanced Research ,Defense Threat Reduction Agency ,Prnewswire Soligenix Inc ,Our Public Health Solutions ,Nasdaq ,Twitter ,Exchange Commission ,National Institute Of Allergy ,Us Congress ,Us Development ,Annual Meeting ,Public Health Solutions ,National Institute ,Infectious Diseases ,Project Bioshield ,Priority Review Voucher ,